Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBioventus Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | $0.05 | $0.05 | $0.05 |
| Q2 2025 | 1 | $0.20 | $0.22 | $0.21 |
| Q3 2025 | 1 | $0.16 | $0.17 | $0.16 |
| Q4 2025 | 1 | $0.18 | $0.19 | $0.19 |
| Q1 2026 | 1 | $0.12 | $0.12 | $0.12 |
| Q2 2026 | 1 | $0.26 | $0.27 | $0.27 |
| Q3 2026 | 1 | $0.24 | $0.26 | $0.25 |
| Q4 2026 | 1 | $0.25 | $0.27 | $0.26 |
Bioventus Inc. Earnings Date And Information
Bioventus Inc. last posted its earnings results on Tuesday, March 11th, 2025. The company reported $0.15 earnings per share for the quarter, topping analysts' consensus estimates of $0.08 by $0.07. The company had revenue of 153.64 M for the quarter and had revenue of 573.28 M for the year. Bioventus Inc. has generated $-1 earnings per share over the last year ($-0.75 diluted earnings per share) and currently has a price-to-earnings ratio of -19.65. Bioventus Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based on prior year's report dates.
Bioventus Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/11/2025 | Q4 2024 | $0.08 | -$0.00 | -0.08 | $145.16 M | $153.64 M |
| 11/05/2024 | Q3 2024 | $0.06 | -$0.07 | -0.13 | N/A | $138.96 M |
| 08/06/2024 | Q2 2024 | $0.07 | -$0.37 | -0.44 | N/A | $151.22 M |
| 05/07/2024 | Q1 2024 | -$0.05 | -$0.07 | -0.02 | $118.37 M | $129.46 M |
| 03/12/2024 | Q4 2023 | $0.06 | -$0.10 | -0.16 | $123.96 M | $135.42 M |
| 11/07/2023 | Q3 2023 | $0.06 | -$0.12 | -0.18 | $119.00 M | $120.79 M |
| 08/08/2023 | Q2 2023 | $0.03 | -$0.06 | -0.09 | N/A | $137.07 M |
| 05/16/2023 | Q1 2023 | -$0.11 | -$1.61 | -1.5 | N/A | $119.06 M |
| 03/31/2023 | Q4 2022 | $0.05 | -$0.72 | -0.77 | N/A | $125.83 M |
| 11/21/2022 | Q3 2022 | $0.13 | -$1.18 | -1.31 | N/A | $128.66 M |
| 08/12/2022 | Q2 2022 | N/A | -$0.13 | N/A | N/A | $140.33 M |
| 05/11/2022 | Q1 2022 | N/A | -$0.24 | N/A | N/A | $117.29 M |
| 03/11/2022 | Q4 2021 | N/A | -$0.01 | N/A | N/A | $130.41 M |
| 11/10/2021 | Q3 2021 | N/A | -$0.03 | N/A | N/A | $108.89 M |
| 08/11/2021 | Q2 2021 | N/A | -$0.10 | N/A | N/A | $109.82 M |
| 05/13/2021 | Q1 2021 | N/A | $0.60 | N/A | N/A | $81.78 M |
| 03/26/2021 | Q4 2020 | N/A | $0.07 | N/A | N/A | $98.59 M |
| 09/30/2020 | Q3 2020 | N/A | $0.15 | N/A | N/A | $85.91 M |
| 06/30/2020 | Q2 2020 | N/A | -$0.10 | N/A | N/A | $58.02 M |
| 03/31/2020 | Q1 2020 | N/A | $0.20 | N/A | N/A | $78.65 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bioventus Inc. Earnings: FAQ's
Bioventus Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based offlast year's report dates.
In the previous quarter, Bioventus Inc. (:BVS) reported $0.15 earnings per share (EPS) to beat the analysts' consensus estimate of $0.08 by $0.07.
The conference call for Bioventus Inc.'s latest earnings report can be listened to online.
The conference call transcript for Bioventus Inc.'s latest earnings report can be read online.
Bioventus Inc. (:BVS) has a recorded annual revenue of $573.28 M.
Bioventus Inc. (:BVS) has a recorded net income of $-49,126,000.Bioventus Inc. has generated $-0.75 earnings per share over the last four quarters.
Bioventus Inc. (:BVS) has a price-to-earnings ratio of -19.65 and price/earnings-to-growth ratio is -1.33.